<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00692757</url>
  </required_header>
  <id_info>
    <org_study_id>5-07-9</org_study_id>
    <nct_id>NCT00692757</nct_id>
  </id_info>
  <brief_title>Wound Antiseptic Study With Hypochlorous Acid &amp; Iodopovidone</brief_title>
  <acronym>WASH</acronym>
  <official_title>Comparative Study of Two Antiseptics Solutions for the Prevention of Surgical Site Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Tecnol贸gica de Pereira</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario San Jorge de Pereira (HUSJ)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Tecnol贸gica de Pereira</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether hypochlorous acid is an effective
      antiseptic agent to prevent surgical site infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A topical antimicrobial that decrease the bacterial bioburden of surgical wounds without
      impairing the wound's ability to heal is a need. A stabilized form of hypochlorous acid has
      been demonstrated in vitro and in animal studies to possess properties that could fulfill
      these criteria but it is imperative to assess its efficacy and safety in humans.

      To assess hypochlorous acid efficacy and safety, it was designed a clinical controlled
      randomized trial to compare hypochlorous acid to iodopovidone, the gold standard, in
      preoperative scrub of surgical area.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">March 2009</completion_date>
  <primary_completion_date type="Anticipated">January 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical site infection rates</measure>
    <time_frame>until one month (weekly)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decreasing Colony Forming Unit count (CFU/mL) after using the skin topic antiseptic in surgical site</measure>
    <time_frame>one week</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">432</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hypochlorous acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Iodopovidone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hypochlorous acid</intervention_name>
    <description>Hypochlorous acid for preoperative scrubbing to prevent surgical site infection in spray</description>
    <arm_group_label>A</arm_group_label>
    <other_name>NVC-101 NovaBay Pharmaceuticals, Inc, Emeryville, CA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iodopovidone</intervention_name>
    <description>Iodopovidone</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients over 18 years old, who are going to be operated

          -  Classification of surgical wounds according to the National Research Council as class
             I or II

          -  Risk index classification of the American Society of Anaesthesiology (ASA) as ASA 1 or
             2

        Exclusion Criteria:

          -  Patients requiring mesh or prosthesis or orthesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliana Buitrago, MD.,MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Tecnol贸gica de Pereira</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliana Buitrago, Master</last_name>
    <phone>313-649-0439</phone>
    <email>julianabuitrago@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario San Jorge (HUSJ)</name>
      <address>
        <city>Pereira</city>
        <state>Risaralda</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodolfo A Cabrales, MD.</last_name>
      <phone>57-6-333-0014</phone>
      <email>rocabster@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>German A Moreno, MD.,MSc</last_name>
      <phone>57-6-333-7126</phone>
      <email>gamo@cable.net.co</email>
    </contact_backup>
    <investigator>
      <last_name>Rodolfo A Cabrales, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <reference>
    <citation>Selkon JB, Cherry GW, Wilson JM, Hughes MA. Evaluation of hypochlorous acid washes in the treatment of chronic venous leg ulcers. J Wound Care. 2006 Jan;15(1):33-7.</citation>
    <PMID>16669304</PMID>
  </reference>
  <reference>
    <citation>Robson MC, Payne WG, Ko F, Mentis M, Donati G, Shafii SM, Culverhouse S, Wang L, Khosrovi B, Najafi R, Cooper DM, Bassiri M. Hypochlorous Acid as a Potential Wound Care Agent: Part II. Stabilized Hypochlorous Acid: Its Role in Decreasing Tissue Bacterial Bioburden and Overcoming the Inhibition of Infection on Wound Healing. J Burns Wounds. 2007 Apr 11;6:e6.</citation>
    <PMID>17492051</PMID>
  </reference>
  <reference>
    <citation>Wang L, Bassiri M, Najafi R, Najafi K, Yang J, Khosrovi B, Hwong W, Barati E, Belisle B, Celeri C, Robson MC. Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. J Burns Wounds. 2007 Apr 11;6:e5.</citation>
    <PMID>17492050</PMID>
  </reference>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2008</study_first_submitted>
  <study_first_submitted_qc>June 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2008</study_first_posted>
  <last_update_submitted>October 20, 2008</last_update_submitted>
  <last_update_submitted_qc>October 20, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2008</last_update_posted>
  <responsible_party>
    <name_title>Juliana Buitrago Jaramillo</name_title>
    <organization>Universidad Tecnol贸gica de Pereira</organization>
  </responsible_party>
  <keyword>Hypochlorous Acid</keyword>
  <keyword>Colony forming units</keyword>
  <keyword>surgical site infection</keyword>
  <keyword>nosocomial infection</keyword>
  <keyword>bacterial bioburden</keyword>
  <keyword>wound healing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

